Ronald Seeliger, CEO of Hemofarm group, arrived in Serbia during turbulent times in CEE. Following a strict program of reinvestment, local expertise, and innovative strategies, Hemofarm surged forwards, developing into the pharmaceutical powerhouse that we see today. In this interview in the newly renovated offices in Belgrade, Seeliger sheds light on Serbia’s skilled workforce, the importance of being a Stada brand and how a little bit of persistence can go a very long way.
What was the impact of acquiring Hemofarm for Stada?
"There is a strong community spirit across the Balkans, and it is one of those countries where people take care of people; the state is not necessarily the first port of call."
